November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies ...

Detailed price information for Harvest Tech Achievers Enh Inc ETF (HTAE-T) from The Globe and Mail including charting and trades.

Later-stage financing deals for cell and gene therapy companies reflects a broader derisking trend in the pharma industry.

Indeed, while U.S. indexes tend to lean toward software and cloud giants, China’s tech market is broader, taking in ...